0001209191-21-070938.txt : 20211222 0001209191-21-070938.hdr.sgml : 20211222 20211222165309 ACCESSION NUMBER: 0001209191-21-070938 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211221 FILED AS OF DATE: 20211222 DATE AS OF CHANGE: 20211222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mylet Johanna CENTRAL INDEX KEY: 0001765988 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39376 FILM NUMBER: 211513858 MAIL ADDRESS: STREET 1: C/O POSEIDA THERAPEUTICS, INC. STREET 2: 4242 CAMPUS POINT COURT, SUITE 700 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Poseida Therapeutics, Inc. CENTRAL INDEX KEY: 0001661460 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 472846548 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9390 TOWNE CENTRE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-779-3100 MAIL ADDRESS: STREET 1: 9390 TOWNE CENTRE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-12-21 0 0001661460 Poseida Therapeutics, Inc. PSTX 0001765988 Mylet Johanna C/O POSEIDA THERAPEUTICS, INC. 9390 TOWNE CENTRE DRIVE, STE 200 SAN DIEGO CA 92121 0 1 0 0 Chief Financial Officer Common Stock 2021-12-21 4 M 0 2616 1.173 A 31131 D Common Stock 2021-12-21 4 M 0 3100 1.933 A 34231 D Stock Option (Right to Buy) 1.173 2021-12-21 4 M 0 2616 0.00 D 2026-02-28 Common Stock 2616 0 D Stock Option (Right to Buy) 1.933 2021-12-21 4 M 0 3100 0.00 D 2028-02-05 Common Stock 3100 3816 D The stock option is fully vested and exercisable. 12.5% of the shares shares subject to the stock option vested and became exercisable on August 6, 2018, and the remaining shares vest in 42 equal monthly installments thereafter. /s/ Harry J. Leonhardt, Attorney-in-Fact 2021-12-22